Urology · Saint Joseph, MO
NPI
1497856702
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
901 Heartland Rd, Suite 1800
Saint Joseph, MO, 64506
Phone (816) 232-8877
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
101,088 services
Medicare patients, 2024
1,669
Average age 77
Drug cost, 2024
$943K
5,984 prescriptions
Company payments, 2025
$707
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark F Lierz was code J1071 (injection, testosterone cypionate, 1 mg), 33,952 times for 16 patients. In total Mark F Lierz billed 101,088 services in 125 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 33,952 | 16 | $0.02 | $516 |
| J0897 Injection, denosumab, 1 mg | Office | 10,680 | 43 | $20.62 | $220K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 6,303 | 59 | $0.10 | $636 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 5,240 | 364 | $34.39 | $180K |
| 84311 Immunoassay | Office | 3,944 | 1,247 | $7.94 | $31K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 2,646 | 44 | $44.42 | $118K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,455 | 303 | $40.30 | $99K |
| 83986 Clinical Chemistry | Office | 2,059 | 1,278 | $3.51 | $7,227 |
| 82247 Clinical Chemistry | Office | 2,059 | 1,278 | $4.92 | $10K |
| 83069 Blood Count | Office | 2,059 | 1,278 | $3.87 | $7,968 |
| 82945 Clinical Chemistry | Office | 2,045 | 1,274 | $3.85 | $7,873 |
| 81007 Clinical Chemistry | Office | 2,035 | 1,267 | $29.38 | $60K |
| 82570 Clinical Chemistry | Office | 2,011 | 1,260 | $5.08 | $10K |
| 84580 Clinical Chemistry | Office | 2,002 | 1,257 | $9.36 | $19K |
| 84156 Clinical Chemistry | Office | 1,976 | 1,245 | $3.60 | $7,114 |
By year: 2022 $977K for 71,995 services; 2023 $1.4M for 84,374 services; 2024 $1.5M for 101,088 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 5,240 | 364 | $34.39 | $180K |
| 84311 Immunoassay | 3,944 | 1,247 | $7.94 | $31K |
| 83069 Blood Count | 2,059 | 1,278 | $3.87 | $7,968 |
| 82247 Clinical Chemistry | 2,059 | 1,278 | $4.92 | $10K |
| 83986 Clinical Chemistry | 2,059 | 1,278 | $3.51 | $7,227 |
| 82945 Clinical Chemistry | 2,045 | 1,274 | $3.85 | $7,873 |
| 81007 Clinical Chemistry | 2,035 | 1,267 | $29.38 | $60K |
| 82570 Clinical Chemistry | 2,011 | 1,260 | $5.08 | $10K |
| 84580 Clinical Chemistry | 2,002 | 1,257 | $9.36 | $19K |
| 84156 Clinical Chemistry | 1,976 | 1,245 | $3.60 | $7,114 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark F Lierz prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,140 prescriptions and refills. In total Mark F Lierz wrote 5,984 Medicare prescriptions that cost $943K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,140 | 2,697 | 309 | $16K |
| Finasteride Generic | 1,007 | 2,585 | 283 | $14K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 570 | 843 | 154 | $14K |
| Myrbetriq Mirabegron | 364 | 509 | 69 | $224K |
| Ciprofloxacin Hcl Generic | 349 | 363 | 222 | $1,384 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 303 | 338 | 181 | $4,227 |
| Dutasteride Generic | 242 | 521 | 69 | $7,743 |
| Oxybutynin Chloride Generic | 229 | 350 | 55 | $3,360 |
| Gemtesa Vibegron | 221 | 309 | 44 | $142K |
| Trimethoprim Generic | 204 | 325 | 51 | $8,648 |
| Fluconazole Generic | 138 | 142 | 90 | $876 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 119 | 182 | 29 | $1,772 |
| Solifenacin Succinate Generic | 118 | 193 | 26 | $4,574 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 101 | 101 | 72 | $533 |
| Testosterone Cypionate Generic | 81 | 123 | 21 | $2,624 |
Brand drugs: 830 claims; generic drugs: 5,154 claims; opioid claims: 80.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark F Lierz $707 ($707 in general payments such as food, travel and fees) from 19 companies. The largest payer was Pfizer Inc. with $110.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 5 | $110 |
| Abbvie Inc. ABBV | 6 | $86.73 |
| Janssen Biotech, Inc. JNJ | 2 | $53.29 |
| Olympus America Inc. | 3 | $52.73 |
| Astellas Pharma US Inc 4503.T | 2 | $51.68 |
| Teleflex LLC TFX | 2 | $41.46 |
| Myriad Genetic Laboratories, Inc. MYGN | 2 | $37.99 |
| Bioprotect Medical, Inc. | 1 | $33.22 |
| Coloplast Corp | 2 | $32.11 |
| Azurity Pharmaceuticals, Inc. | 2 | $32.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.